A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)
Sarcoma Oncology Research Center, LLC
Oncternal Therapeutics, Inc
Hutchmed
Bayer
Bristol-Myers Squibb
Eisai Inc.
Dana-Farber Cancer Institute
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)